SCIL FY26 Annual Report: Record PAT of Rs 543 Cr; leadership transition announced
SUMICHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
SCIL FY25-26 revenue rose 3% to Rs 3,238 Cr. Record Profit After Tax of Rs 543 Cr (up 7%, all-time high). EBITDA margin at 20.7% (vs 20.1%), PAT margin 16.8% (vs 16.1%), ROCE at 31% (vs 29%). Company stayed debt-free, net worth up 17% to Rs 3,394 Cr. Dividend of Rs 1.30 per share declared. Herbicides up 19% on strong Lentigo and Mera 71 growth. Leadership shift: Chairman Dr Mukul Asher ends term 31 Aug 2026; MD Chetan Shah to non-executive role; Dr Suresh Ramachandran elevated as MD from 1 Sep 2026. AGM on 27 July 2026.
Record profits, margin gains, debt-free balance sheet, and steady dividend. Board transition is internal and continuity-led, broadly neutral for shareholders.